Herein we have provided evidence of a novel therapeutic strategy to be exploited for the treatment of triple-negative breast cancer and potentially other breast cancer subtypes where PEA3 regulates Notch-1 and Notch-4. The gene discussed is ETV4; the disease is breast cancer.